MARK C. MILLER - 20 May 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
20 May 2021
Net transactions value
$0
Form type
4
Filing time
24 May 2021, 21:59:23 UTC
Next filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Stock Option (right to buy) Award $0 +17,584 $0.000000 17,584 20 May 2021 Common Stock 17,584 $7.68 Direct F1
transaction AXDX Restricted Stock Units Award $0 +4,396 $0.000000 4,396 20 May 2021 Common Stock 4,396 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on May 20, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units vest in full on May 20, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F4 Not applicable.